Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation.
Chen
Jeon-Hor
JH
John Tu and Thomas Yuen Center for Functional Onco-Imaging, University of California Irvine, Irvine Hall 164, Irvine, CA 92697, USA. jeonhc@uci.edu
Nie
Ke
K
Bahri
Shadfar
S
Hsu
Chieh-Chih
CC
Hsu
Fei-Ting
FT
Shih
Han-Ni
HN
Lin
Muqing
M
Nalcioglu
Orhan
O
Su
Min-Ying
MY
D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D001952:Bridged-Ring Compounds / Q000008:administration & dosage; D003287:Contrast Media; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods*; D021621:Imaging, Three-Dimensional; D016014:Linear Models; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D018709:Statistics, Nonparametric; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome
D001952:Bridged-Ring Compounds; D003287:Contrast Media; D043823:Taxoids; C080625:taxane; D004317:Doxorubicin; D003520:Cyclophosphamide